Investing in drugmakers: uncommon profits from curing rare diseases
MoneyWeek cover illustration
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
GlaxoSmithKline is set to cut its dividend – should you sell your shares?
Glaxo drug production line
Biotech stocks

GlaxoSmithKline is set to cut its dividend – should you sell your shares?

GlaxoSmithKline, a top pick for UK income investors, will reduce its dividend after spinning out its consumer healthcare business. So should you sell?…
22 Apr 2022
The mistakes pharmaceutical companies made with their Covid vaccines
Old lady getting a Covid jab
Biotech stocks

The mistakes pharmaceutical companies made with their Covid vaccines

Covid-19 looked as if it would mark the start of a golden age for the pharmaceutical industry. It’s not worked out that way, says Matthew Lynn.
19 Mar 2022
Veterinary medicine stocks: the firms keeping your pet healthy
MoneyWeek cover illustration - a cat in hospital
Share tips

Veterinary medicine stocks: the firms keeping your pet healthy

Pet ownership has grown due to the pandemic. That’s good news for animal health stocks, says Dr Mike Tubbs
11 Mar 2022
How Covid-19 changed biotechnology – and how you can invest
MoneyWeek cover image – biotech
Biotech stocks

How Covid-19 changed biotechnology – and how you can invest

The pandemic has exacted a huge human and financial toll, but it has also transformed scientific research in ways that will deliver huge benefits for …
4 Mar 2022
The best vaccine-makers’ stocks to buy now
Biotech stocks

The best vaccine-makers’ stocks to buy now

The rapid development of Covid-19 vaccines has already saved many lives and made huge profits for a few pharmaceutical firms. Investors should keep an…
13 Jan 2022
Three biotech stocks to buy now
Share tips

Three biotech stocks to buy now

Professional investors Ailsa Craig and Marek Poszepczynski of the International Biotechnology Trust pick three of their favourite biotech stocks to bu…
10 Jan 2022
Cover of MoneyWeek magazine issue no 1022, Friday 23 October 2020

Subscribe to MoneyWeek and get your first six issues FREE

Subscribe to MoneyWeek now and get your first six magazine issues absolutely FREE
Get healthy returns from these three innovative healthcare stocks
Share tips

Get healthy returns from these three innovative healthcare stocks

Professional investor Michael Li of the American Century Advanced Medical Impact Fund looks at three healthcare stocks
28 Dec 2021
Stéphane Bancel: Moderna’s biotech whizz who changed the world
People

Stéphane Bancel: Moderna’s biotech whizz who changed the world

Stéphane Bancel had a safe job as CEO of a French multinational when he decided to risk it all on a promising but unproven medical technology. The bet…
12 Dec 2021
The huge potential of mRNA technology
Biotech stocks

The huge potential of mRNA technology

The new technology made its name when it delivered Covid-19 vaccines in record time. But it could be pressed into use in many other areas too. Simon W…
28 Oct 2021
Get healthy returns from these three healthcare stocks
Share tips

Get healthy returns from these three healthcare stocks

Professional investor Paul Major of the BB Healthcare Trust highlights three of his favourite healthcare stocks.
25 Oct 2021
University spin-outs: where to find companies involved in cutting-edge science
Share tips

University spin-outs: where to find companies involved in cutting-edge science

Universities are innovation incubators and often launch businesses involved in fast-growing fields ranging from biotechnology to artificial intelligen…
24 Sep 2021
AstraZeneca’s Covid troubles could see it pull out of making vaccines
Biotech stocks

AstraZeneca’s Covid troubles could see it pull out of making vaccines

AstraZeneca has suffered a series of setbacks with its Covid-19 jab and may exit the inoculation subsector altogether. Matthew Partridge reports
6 Aug 2021
A great leap forward in the war against Alzheimer’s disease
Biotech stocks

A great leap forward in the war against Alzheimer’s disease

The approval of the first drug to treat the neurodegenerative disease in 18 years will galvanise research in the entire subsector, says Dr Mike Tubbs.…
16 Jul 2021
Shake-up at GSK won’t placate investors
UK stockmarkets

Shake-up at GSK won’t placate investors

GSK has launched a radical shakeup of its operations, but that's unlikely to satisfy investors unhappy with the drugmaker's perennial underperformance…
2 Jul 2021
Two investment trusts that have proved their worth
Investment trusts

Two investment trusts that have proved their worth

These two investment trusts have earned investors’ confidence since their flotations and remain solid bets, says Max King.
25 Jun 2021
Investing in stem cells, the building blocks of the body
Share tips

Investing in stem cells, the building blocks of the body

Stem cells have always been tomorrow’s technology. But it looks as though their time has finally come – and they will transform the treatment of disea…
18 Jun 2021
Why Joe Biden’s Big Pharma patent grab is a terrible idea
Biotech stocks

Why Joe Biden’s Big Pharma patent grab is a terrible idea

The US president has proposed waiving patents on Covid-19 vaccines in a bid to boost global supply. But it won’t work on its own terms and holds dange…
22 May 2021
How to invest in the fight against Alzheimer’s disease
Biotech stocks

How to invest in the fight against Alzheimer’s disease

The cost of caring for those with dementia is a growing problem for healthcare systems around the world. Any firm that develops an effective treatment…
21 May 2021
A show of support for GlaxoSmithKline's hedge fund fight
Biotech stocks

A show of support for GlaxoSmithKline's hedge fund fight

Several large shareholders have said that they will support GlaxoSmithKline in its battle with hedge fund Elliott Management.
21 May 2021
How to invest in biotechnology: the healthcare sector’s high-growth area
Biotech stocks

How to invest in biotechnology: the healthcare sector’s high-growth area

Dr Mike Tubbs provides an overview of this thriving industry, whose latest triumphs include the Covid-19 vaccines. He examines the best investment str…
14 May 2021
Vaccine patents: a bitter pill for drug companies
Biotech stocks

Vaccine patents: a bitter pill for drug companies

The US has suggested waiving drug companies’ vaccine patents to hasten the defeat of Covid-19, sending their share prices down.
14 May 2021